Additional treatment with the mTOR pathway inhibitor rapamycin significantly potentiated the toxic effects of the SA/GT11 combination, indicating a cooperative effect of the two pathways in inducing cancer cell death (Fig. 7g and Supplementary Fig. 6c). Here, MTOR is linked to cancer.